Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies

• Jianmei W. Leavenworth,
• Jianmei W. Leavenworth,
• Jianmei W. Leavenworth,
• Xindong Liu,
• Yunfeng Ma,
• Yibei Zhu,
• Chunjian Qi

Affiliations

Jianmei W. Leavenworth

Department of Neurosurgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States

Jianmei W. Leavenworth

The O’Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States

Jianmei W. Leavenworth

Department of Microbiology, Heersink School of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States

Xindong Liu

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China

Yunfeng Ma

School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, China

Yibei Zhu

Department of Immunology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China

Chunjian Qi

Medical Research Center, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Changzhou, China